Bone loss is a common problem for individuals with inflammatory bowel disea
se. Corticosteroids play an important role in the development of osteoporos
is in these patients; however, active disease and longer disease duration a
lso appear to increase the risk of osteoporosis. Given the current burden o
f osteoporosis, bone mineral density is recommended.